| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| MANNKIND CORP | Chief Financial Officer | Common Stock, $.01 Par Value | 233K | $1M | $4.31 | May 15, 2024 | Direct |
| MANNKIND CORP | Chief Financial Officer | Performance Restricted Stock Unit | 158K | May 15, 2024 | Direct | ||
| Adamas Pharmaceuticals Inc | Chief Financial Officer | Common Stock | 0 | $5.16 | Nov 24, 2021 | Direct | |
| Adamas Pharmaceuticals Inc | Chief Financial Officer | Stock Option (Right to Buy) | 0 | Nov 24, 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| MNKD | MANNKIND CORP | May 15, 2024 | 3 | $0 | 4 | May 17, 2024 | Chief Financial Officer |
| MNKD | MANNKIND CORP | Apr 22, 2024 | 0 | $0 | 3 | Apr 22, 2024 | Chief Financial Officer |
| ADMS | Adamas Pharmaceuticals Inc | Nov 24, 2021 | 4 | $0 | 4 | Nov 24, 2021 | Chief Financial Officer |